Yongxing Bao
Overview
Explore the profile of Yongxing Bao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
300
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu Y, Men Y, Yang X, Sun S, Bao Y, Ma Z, et al.
Radiat Oncol
. 2025 Mar;
20(1):38.
PMID: 40082994
Background: The ADAURA study indicated that adjuvant TKI therapy improves survival in postoperative patients with EGFR-mutated (EGFRm) non-small-cell lung cancer (NSCLC), especially in stage III disease. However, the effect of...
2.
Ma Z, Liu Y, Bao Y, Wang M, Yang X, Men Y, et al.
Lung Cancer
. 2024 Dec;
199:108063.
PMID: 39700682
Purpose: The therapeutic advantage of postoperative radiation therapy (PORT) for non-small cell lung cancer (NSCLC) has not been shown to benefit overall survival (OS) according to two randomized controlled trials...
3.
Cheng Y, Zhang W, Wu L, Zhou C, Wang D, Xia B, et al.
JAMA Oncol
. 2024 Nov;
11(1):16-25.
PMID: 39541202
Importance: Patients with extensive-stage small cell lung cancer (ES-SCLC) have poor prognoses and unmet medical needs. Objective: To evaluate the efficacy and safety of toripalimab plus etoposide and platinum-based chemotherapy...
4.
Zhai Y, Zhang Y, Hui Z, Bao Y, Zhou H, Tang Y, et al.
BMC Med Educ
. 2024 Nov;
24(1):1300.
PMID: 39538173
Purpose: This study explored the effectiveness of a Problem-based Learning (PBL) teaching model on the WeChat public platform for radiation oncology residency training programs. Materials And Methods: The WeChat PBL...
5.
Zheng Y, Chen C, Lu C, Bao Y, Zhang W, Liang H, et al.
Biomol Biomed
. 2024 Nov;
PMID: 39524006
Inflammation and coagulation cascades are closely correlated with cancer occurrence and progression. This study investigated the prognostic value of the combination of plasma fibrinogen level and neutrophil-to-lymphocyte ratio (F-NLR) in...
6.
Ma Z, Liu Y, Bao Y, Liu Q, Yang X, Men Y, et al.
BMC Cancer
. 2024 Aug;
24(1):968.
PMID: 39112971
Introduction: The estimated dose of radiation to immune cells (EDRIC) has been shown to correlate with the overall survival (OS) of patients who receive definitive thoracic radiotherapy. However, the planning...
7.
Liu Y, Ma Z, Bao Y, Wang X, Men Y, Sun X, et al.
Heliyon
. 2024 Jul;
10(13):e33702.
PMID: 39050414
Purpose: We aimed to integrate MR radiomics and dynamic hematological factors to build a model to predict pathological complete response (pCR) to neoadjuvant chemoradiotherapy (NCRT) in esophageal squamous cell carcinoma...
8.
Ji J, Liu Y, Bao Y, Men Y, Wang J, Hui Z
Adv Radiat Oncol
. 2024 Jun;
9(7):101522.
PMID: 38826154
Purpose: Initial studies investigating the combination of local and systemic treatments in advanced esophageal cancer (EC) have conflicting conclusions regarding survival benefits. The objective of this systematic review and meta-analysis...
9.
Ma Z, Men Y, Liu Y, Bao Y, Liu Q, Yang X, et al.
Cancer Imaging
. 2024 May;
24(1):61.
PMID: 38741207
Background: The value of postoperative radiotherapy (PORT) for patients with non-small cell lung cancer (NSCLC) remains controversial. A subset of patients may benefit from PORT. We aimed to identify patients...
10.
Ji J, Liu Y, Bao Y, Men Y, Hui Z
Urol Oncol
. 2024 Apr;
42(8):249.e1-249.e11.
PMID: 38653593
Introduction: Clear cell renal cell carcinoma is the most common type of kidney cancer, but the prediction of prognosis remains a challenge. Methods: We collected whole-slide histopathological images, corresponding clinical...